PURPOSE OF REVIEW: Intracranial atherosclerotic disease (IAD) is likely the most common cause of stroke world-wide and is associated with a very high risk of recurrence. It results in cerebral ischemia due to a variety of mechanisms, including artery-to-artery embolism, hemodynamic failure, and occlusion of penetrating arteries. New imaging modalities focused on physiological consequences of IAD have become available and recent treatment trials have been completed. RECENT FINDINGS: We review the traditional imaging modalities, emphasizing the advantages and limitations of each method, and discuss the novel physiological approaches that interrogate physiological process to indicate specific mechanisms of ischemia. These allow deeper understanding of the pathophysiological processes that underlie IAD-related ischemia. The key findings of recent therapeutic trials are reviewed, including the landmark randomized studies showing advantage of antiplatelet agents and risk factor modification, and a significant risk of complications with endovascular approaches. SUMMARY: Current evidence argues for aggressive medical management and suggests caution with interventional treatments. We propose that mechanistic information will further refine the risk assessment of patients with IAD to offer targeted therapy.
PURPOSE OF REVIEW: Intracranial atherosclerotic disease (IAD) is likely the most common cause of stroke world-wide and is associated with a very high risk of recurrence. It results in cerebral ischemia due to a variety of mechanisms, including artery-to-artery embolism, hemodynamic failure, and occlusion of penetrating arteries. New imaging modalities focused on physiological consequences of IAD have become available and recent treatment trials have been completed. RECENT FINDINGS: We review the traditional imaging modalities, emphasizing the advantages and limitations of each method, and discuss the novel physiological approaches that interrogate physiological process to indicate specific mechanisms of ischemia. These allow deeper understanding of the pathophysiological processes that underlie IAD-related ischemia. The key findings of recent therapeutic trials are reviewed, including the landmark randomized studies showing advantage of antiplatelet agents and risk factor modification, and a significant risk of complications with endovascular approaches. SUMMARY: Current evidence argues for aggressive medical management and suggests caution with interventional treatments. We propose that mechanistic information will further refine the risk assessment of patients with IAD to offer targeted therapy.
Authors: David J Fiorella; Aquilla S Turk; Elad I Levy; G Lee Pride; Henry H Woo; Felipe C Albuquerque; Babu G Welch; David B Niemann; Beverly Aagaard-Kienitz; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall Journal: Stroke Date: 2011-06-02 Impact factor: 7.914
Authors: Martin Roubec; Martin Kuliha; Tomás Jonszta; Václav Procházka; Tána Fadrná; Michal Filip; Petr Kanovsky; Katerina Langová; Roman Herzig; David Skoloudík Journal: J Ultrasound Med Date: 2011-08 Impact factor: 2.153
Authors: Limin Zhao; Kristian Barlinn; Vijay K Sharma; Georgios Tsivgoulis; Luis F Cava; Spyros N Vasdekis; Hock Luen Teoh; Nikos Triantafyllou; Bernard P L Chan; Arvind Sharma; Konstantinos Voumvourakis; Elefterios Stamboulis; Maher Saqqur; Mark R Harrigan; Karen C Albright; Andrei V Alexandrov Journal: Stroke Date: 2011-09-29 Impact factor: 7.914
Authors: J D Fields; B D Petersen; H L Lutsep; G M Nesbit; K C Liu; A Dogan; D S Lee; W M Clark; S L Barnwell Journal: Interv Neuroradiol Date: 2011-06-20 Impact factor: 1.610
Authors: David S Liebeskind; George A Cotsonis; Jeffrey L Saver; Michael J Lynn; Tanya N Turan; Harry J Cloft; Marc I Chimowitz Journal: Ann Neurol Date: 2011-03-17 Impact factor: 10.422
Authors: Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft Journal: N Engl J Med Date: 2011-09-07 Impact factor: 91.245
Authors: Robin Lemmens; Søren Christensen; Matus Straka; Deidre A De Silva; Michael Mlynash; Bruce C V Campbell; Roland Bammer; Jean-Marc Olivot; Patricia Desmond; Michael P Marks; Stephen M Davis; Geoffrey A Donnan; Gregory W Albers; Maarten G Lansberg Journal: Int J Stroke Date: 2013-12-23 Impact factor: 5.266
Authors: Ido R van den Wijngaard; Ghislaine Holswilder; Marianne A A van Walderveen; Ale Algra; Marieke J H Wermer; Osama O Zaidat; Jelis Boiten Journal: Brain Behav Date: 2016-08-31 Impact factor: 2.708